HIGHLIGHTS
- who: Exogenous Testosterone Use and collaborators from the Urology, University of Miami, Miami, USA Medicine, Florida International University, Miami, USA have published the research work: Received 03/08/2022 Review began 03/24/2022 Review ended 05/16/2022 Published 06/10/2022, in the Journal: (JOURNAL) of June/10,/2022
- what: HCG dosing appears to maintain T levels in men transitioning off exogenous T. Men with baseline labs completed outside their previous T therapy therapeutic time window before initiating hCG monotherapy had a statistically significant increase in mean T levels and a decrease in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.